is retatrutide a glp-1 drug vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Retatrutide for weight loss: Study

Biotech and pharmaceutical companies are rushing to form partnerships, secure licensing rights and fund the development of new drugs that target obesity, diabetes and metabolic disorders

However, when the dosage was increased, they suffered bad side effects, leading them to stop taking the medication

In the first study by Cesta et al

This meta-analysis showed that, over 398 patients with schizophrenia treated with antipsychotic followed up between 12 and 24 weeks, the GLP-1RAs liraglutide and exenatide were superior to placebo for body weight, waist circumference, BMI and blood pressure 134

& Rothberg, M

This content is not a substitute for professional medical advice or diagnosis